LBRX
LBRX
NASDAQ · Pharmaceuticals

Lb Pharmaceuticals Inc

$38.09
-2.76 (-6.76%)
As of Nov 6, 2:10 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -60.1% upside
Low Target $11.61
Average Target $15.21
High Target $18.52
Current Price $38.09
Current
$38.09
Target
$15.21
$11.61 $15.21 avg $18.52
Scenario Analysis
Bear Case
$11.61
-69.5%
Low target
Base Case
$15.21
-60.1%
Avg target
Bull Case
$18.52
+-51.4%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$50.16
-24.1% from high
52-Week Low
$14.32
+166.0% from low
Target vs 52W High
$15.21
-69.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%